Company Filing History:
Years Active: 2012-2018
Title: Irma Järvelä: Innovator in Genetic Research
Introduction
Irma Järvelä is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of genetic research, particularly in understanding adult-type hypolactasia. Her work has implications for diagnosing and managing lactose intolerance, a condition affecting many individuals worldwide.
Latest Patents
Irma Järvelä holds a patent for the identification of a DNA variant associated with adult-type hypolactasia. The patent describes a nucleic acid molecule that includes a 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene. This invention is crucial for testing the presence of or predisposition to adult-type hypolactasia through the analysis of a specific SNP contained in the nucleic acid molecule. Additionally, the patent includes diagnostic compositions and kits that aid in detecting this condition.
Career Highlights
Irma Järvelä is affiliated with the National Public Health Institute, where she conducts her research. Her work has garnered attention for its potential to improve the quality of life for individuals with lactose intolerance. With her innovative approach, she has positioned herself as a key figure in genetic research.
Collaborations
Irma has collaborated with notable colleagues, including Leena Peltonen and Nabil Enattah. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the field.
Conclusion
Irma Järvelä's contributions to genetic research, particularly in the area of adult-type hypolactasia, highlight her role as an influential inventor. Her patent and ongoing work continue to pave the way for advancements in diagnostic methods and patient care.